Product Program year 2025 Source: CMS Open Payments

Supera

Device Structural Heart

PDI 08717648226328

Open in the dashboard

General payments

$210,946

835 payments

Research payments

$0

0 payments

Through program year 2025, $210,946 in general payments and $0 in research payments were reported against Supera (Structural Heart).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $210,946 835

Breakdown

Who paid General payments · program year 2025
  1. Abbott Laboratories $210,946 835 payments
Top recipients General payments · program year 2025
  1. Damian Grovas Abad Interventional Cardiology · San Juan, PR $56,615 27% · 42 payments
  2. Prakash Krishnan Interventional Cardiology · New York, NY $21,075 10% · 8 payments
  3. Edwin I Perez Marrero Interventional Cardiology · San Juan, PR $15,406 7% · 31 payments
  4. Matthew Bunte Interventional Cardiology · Kansas City, MO $9,688 5% · 3 payments
  5. Malcom Foster Internal Medicine · Jacksonville, FL $9,300 4% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $134,601 64% · 86 practitioners
  2. Vascular Surgery Surgery $20,072 10% · 61 practitioners
  3. Cardiovascular Disease Internal Medicine $17,177 8% · 56 practitioners
  4. Internal Medicine $16,206 8% · 11 practitioners
  5. Vascular Neurology Psychiatry & Neurology $4,635 2% · 2 practitioners

The top 5 of 37 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Puerto Rico $83,379 40% · 19 recipients
  2. New York $26,210 12% · 13 recipients
  3. Texas $23,231 11% · 57 recipients
  4. Missouri $12,047 6% · 10 recipients
  5. California $11,483 5% · 47 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

835 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record